• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人群中D变异体的分子和血清学分析以及7个新型RHD等位基因的鉴定。

Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.

作者信息

Wen Jizhi, Jia Shuangshuang, Wang Zhen, Chen Jingwang, Liang Qianni, Wei Ling, Richard Gaëlle, Fichou Yann, Luo Guangping, Ji Yanli

机构信息

Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China.

The Key Medical Laboratory of Guangzhou, Guangzhou, People's Republic of China.

出版信息

Transfusion. 2023 Feb;63(2):402-414. doi: 10.1111/trf.17186. Epub 2022 Nov 16.

DOI:10.1111/trf.17186
PMID:36382965
Abstract

BACKGROUND

The molecular basis of the D variant phenotype in the Chinese differs greatly from that of the Caucasian. Adapting a specific D typing strategy to the spectrum of prevalent RHD variant alleles is necessary.

STUDY DESIGN AND METHODS

Blood samples with ambiguous D phenotypes were collected in the Southern Chinese population. A special three-step typing strategy was applied. First, the common DVI type 3 was identified from epitope profiles of D antigen. Then, another common weak D type 15 (RHD*845A) was identified by epitope profiles of D antigen and Sanger sequencing of RHD exon 6. Finally, the remaining D variants were genotyped mainly by Sanger sequencing. For the novel RHD alleles in the coding region and exon-intron junction, in vitro transfection and minigene splicing assays were performed, respectively. The anti-D investigation was performed.

RESULTS

DVI type 3 (65/253, 25.7%) and weak D type 15 (62/253, 24.5%) were common Chinese D variants, and RHD960A, DFR, RHDweak D type 25, 72, and 136 were frequent variant RHD alleles. Besides, twenty-two sporadic and seven novel RHD alleles (RHD188A; RHD688C; RHD782 T; RHD1181C; RHD165 T, 993A; RHD148 + 3G > T and RHD*1227 + 5G > C) were identified. The deleterious effect of the novel RHD alleles on D antigen or mRNA expression was confirmed. Anti-D was detected in two DVI type 3 pregnant women.

DISCUSSION

The three-step typing strategy provides an effective approach for Chinese D variant typing. It can be anticipated that commercially available RHD genotyping kits have limitations for testing Chinese D variants, as some of the frequent variants are not interrogated.

摘要

背景

中国人D变异型表型的分子基础与白种人大不相同。有必要针对常见的RHD变异等位基因谱采用特定的D分型策略。

研究设计与方法

收集中国南方人群中D表型不明确的血样。应用一种特殊的三步分型策略。首先,从D抗原的表位谱中鉴定出常见的DVI 3型。然后,通过D抗原的表位谱和RHD外显子6的桑格测序鉴定出另一种常见的弱D 15型(RHD*845A)。最后,其余的D变异型主要通过桑格测序进行基因分型。对于编码区和外显子-内含子交界处的新型RHD等位基因,分别进行了体外转染和小基因剪接试验。进行了抗-D检测。

结果

DVI 3型(65/253,25.7%)和弱D 15型(62/253,24.5%)是常见的中国D变异型,RHD960A、DFR、RHD弱D 25型、72型和136型是常见的变异RHD等位基因。此外,还鉴定出22个散发性和7个新型RHD等位基因(RHD188A;RHD688C;RHD782T;RHD1181C;RHD165T,993A;RHD148+3G>T和RHD*1227+5G>C)。证实了新型RHD等位基因对D抗原或mRNA表达的有害作用。在两名DVI 3型孕妇中检测到了抗-D。

讨论

三步分型策略为中国D变异型分型提供了一种有效的方法。可以预见,市售的RHD基因分型试剂盒在检测中国D变异型方面存在局限性,因为一些常见变异未被检测到。

相似文献

1
Molecular and serological analysis of the D variant in the Chinese population and identification of seven novel RHD alleles.中国人群中D变异体的分子和血清学分析以及7个新型RHD等位基因的鉴定。
Transfusion. 2023 Feb;63(2):402-414. doi: 10.1111/trf.17186. Epub 2022 Nov 16.
2
RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay.运用多重连接依赖探针扩增法对中国南方汉族D+、D-和D变异型献血者进行RHD基因分型及合子型分析。
Vox Sang. 2017 Oct;112(7):660-670. doi: 10.1111/vox.12554. Epub 2017 Aug 18.
3
RHD variants in Flanders, Belgium.比利时弗拉芒地区的风湿性心脏病(RHD)变体
Transfusion. 2015 Jun;55(6 Pt 2):1411-7. doi: 10.1111/trf.12947. Epub 2014 Nov 21.
4
Molecular basis of serological weak D phenotypes and RhD typing discrepancies identified in the Korean population.韩国人群中血清学弱 D 表型和 RhD 定型差异的分子基础。
Blood Transfus. 2021 Jul 9;19(4):327-334. doi: 10.2450/2020.0128-20. Epub 2020 Oct 9.
5
Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management.澳大利亚具有弱 D 表型献血者中多样且新型的 RHD 变体:对输血管理的影响
Vox Sang. 2017 Apr;112(3):279-287. doi: 10.1111/vox.12488. Epub 2017 Feb 20.
6
Molecular basis and zygosity determination of D variants including identification of four novel alleles in Chinese individuals.D 变异体的分子基础和二倍型确定,包括在中国个体中鉴定出四个新的等位基因。
Transfusion. 2015 Jan;55(1):137-43. doi: 10.1111/trf.12797. Epub 2014 Jul 29.
7
Partial D phenotypes and genotypes in the Chinese population.中国人部分 D 表型和基因型。
Transfusion. 2012 Feb;52(2):241-6. doi: 10.1111/j.1537-2995.2011.03266.x. Epub 2011 Jul 25.
8
Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles.建立一种高通量方法对 RHD 变异进行基因分型,并报告九个新的罕见等位基因。
Transfusion. 2013 Aug;53(8):1821-8. doi: 10.1111/trf.12009. Epub 2012 Dec 11.
9
Impact of RHD genotyping on transfusion practice in Denmark and the United States and identification of novel RHD alleles.RHD 基因分型对丹麦和美国输血实践的影响及新 RHD 等位基因的鉴定。
Transfusion. 2021 Jan;61(1):256-265. doi: 10.1111/trf.16100. Epub 2020 Sep 25.
10
Serological and molecular characterisation of the most prevalent weak D variants in Croatian population.克罗地亚人群中最常见的弱 D 变异体的血清学和分子特征分析。
Transfus Med. 2023 Apr;33(2):132-136. doi: 10.1111/tme.12944. Epub 2022 Dec 1.

引用本文的文献

1
A Bioinformatically Initiated Approach to Evaluate GATA1 Regulatory Regions in Samples with Weak D, Del, or D- Phenotypes Despite Normal Exons.一种通过生物信息学启动的方法,用于评估外显子正常但具有弱D、Del或D-表型的样本中的GATA1调控区域。
Transfus Med Hemother. 2024 May 10;51(4):252-264. doi: 10.1159/000538469. eCollection 2024 Aug.
2
Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).《分子定义的亚洲型 DEL(c.1227G>A)女性中 Rho(D)免疫球蛋白指南》。
Ann Lab Med. 2024 Jul 1;44(4):307-313. doi: 10.3343/alm.2023.0356. Epub 2024 Feb 22.